Nakasone, Mayumi; Lopes, Marta Heloísa 
; Sartori, Ana Marli Chritovam; Sandoval, Eliane Partite Nobre; Villaca, Paula Ribeiro; D'amico, Elbio Antonio; Carneiro, Jorge David Aivazoglou
Subjects: HEMOFILIA, HEMORRAGIA, HEPATITE A
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKASONE, Mayumi et al. Immunogenicity, long term protection and safety of subcutaneous administration of hepatitis A vaccine in patients with hemophilia and other bleeding disorders: a randomized study. Vaccine, v. 38, n. 26, p. 4162-4166, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2020.04.040. Acesso em: 23 maio 2024.APA
Nakasone, M., Lopes, M. H., Sartori, A. M. C., Sandoval, E. P. N., Villaca, P. R., D'amico, E. A., & Carneiro, J. D. A. (2020). Immunogenicity, long term protection and safety of subcutaneous administration of hepatitis A vaccine in patients with hemophilia and other bleeding disorders: a randomized study. Vaccine, 38( 26), 4162-4166. doi:10.1016/j.vaccine.2020.04.040NLM
Nakasone M, Lopes MH, Sartori AMC, Sandoval EPN, Villaca PR, D'amico EA, Carneiro JDA. Immunogenicity, long term protection and safety of subcutaneous administration of hepatitis A vaccine in patients with hemophilia and other bleeding disorders: a randomized study [Internet]. Vaccine. 2020 ; 38( 26): 4162-4166.[citado 2024 maio 23 ] Available from: https://doi.org/10.1016/j.vaccine.2020.04.040Vancouver
Nakasone M, Lopes MH, Sartori AMC, Sandoval EPN, Villaca PR, D'amico EA, Carneiro JDA. Immunogenicity, long term protection and safety of subcutaneous administration of hepatitis A vaccine in patients with hemophilia and other bleeding disorders: a randomized study [Internet]. Vaccine. 2020 ; 38( 26): 4162-4166.[citado 2024 maio 23 ] Available from: https://doi.org/10.1016/j.vaccine.2020.04.040
